Financial News
Nanoviricides Inc (NY: NNVC )
2.340
+0.050
(+2.18%)
Streaming Delayed Price
Updated: 2:08 PM EDT, Jul 23, 2024
Add to My Watchlist
Headline News about Nanoviricides Inc
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/premkt_movers_562.png)
![](/images/schema-image-default.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/vaccine-6165772_1280.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/screenshot_2021-12-20_at_2.46.27_pm.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/photo-1599493758267-c6c884c7071f.jpeg)
NanoViricides Says Its Nanomedicine Tech Could Be the Key To Defeating Omicron and Other COVID-19 Variants
December 09, 2021
Via Benzinga
Exposures
COVID-19
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/photo-1611694554696-e5a46f5015bf.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/covid-19.jpg)
EXCLUSIVE: NanoViricides Completes Oral Gummies, Lung Inhalation Formulations For COVID-19 Treatment
November 15, 2021
Via Benzinga
Exposures
COVID-19
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-pre-market.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/pill-_image_by_arek_socha_from_pixabay__9.jpg)
EXCLUSIVE: NanoViricides Develops Chewable Pills, Lung Inhalation Formulations For COVID-19 Candidate
November 15, 2021
Via Benzinga
Exposures
COVID-19
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/pexels-artem-podrez-5726794_3.jpg)
Todos Medical Says It Wants to Outfox COVID-19 & Cancer Along With Rivals Pfizer & Merck With New Theranostic Approach
November 05, 2021
Via Benzinga
Exposures
COVID-19
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/photo-1608451643043-6a8eebc527ee_0.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/julia-koblitz-rloawxt2fea-unsplash_0.jpg)
NanoViricides COVID-19 Treatment Candidate Found Effective Against Coronavirus Variants In Lab Study
October 11, 2021
Via Benzinga
Exposures
COVID-19
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/louis-reed-pwckf7l4-no-unsplash_4.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day_movers_image_26.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/premkt_movers_456.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_290.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day_movers_image_23.jpg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medic-563423_1920_398_57.jpg?width=720)
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600molecule.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_1910.png)
EXCLUSIVE: NanoViricides' Remdesivir-Encapsulated COVID-19 Therapy Shows Encouraging Preclinical Safety Profile
September 21, 2021
Via Benzinga
Exposures
COVID-19
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day_movers_image_18.jpg)
38 Stocks Moving In Wednesday's Mid-Day Session
September 15, 2021
Via Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_288.png)
53 Biggest Movers From Yesterday
September 16, 2021
Via Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/premkt_movers_448.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_287.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day_movers_image_16.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_372.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/premkt_movers_447.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_1819.png)
EXCLUSIVE: NanoViricides Beefs Up Its COVID-19 Pipeline With TheraCour Licensing Pact
September 14, 2021
Via Benzinga
Exposures
COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.